To evaluate the efficacy and safety of intravitreal bevacizumab ( Avastin ; Genentech , South San Francisco , CA ) in patients with neovascular age-related macular degeneration ( nAMD ) using @ different treatment regimens in which patients were assessed clinically at up to @-week intervals .